BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 18997617)

  • 21. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.
    Finberg KE; Sequist LV; Joshi VA; Muzikansky A; Miller JM; Han M; Beheshti J; Chirieac LR; Mark EJ; Iafrate AJ
    J Mol Diagn; 2007 Jul; 9(3):320-6. PubMed ID: 17591931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mucinous cells in type 1 pulmonary congenital cystic adenomatoid malformation as mucinous bronchioloalveolar carcinoma precursors.
    Lantuejoul S; Nicholson AG; Sartori G; Piolat C; Danel C; Brabencova E; Goldstraw P; Brambilla E; Rossi G
    Am J Surg Pathol; 2007 Jun; 31(6):961-9. PubMed ID: 17527088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucinous versus nonmucinous solitary pulmonary nodular bronchioloalveolar carcinoma: CT and FDG PET findings and pathologic comparisons.
    Lee HY; Lee KS; Han J; Kim BT; Cho YS; Shim YM; Kim J
    Lung Cancer; 2009 Aug; 65(2):170-5. PubMed ID: 19111932
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
    Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
    Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
    Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
    Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence of abortive plasma cell differentiation in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.
    Buettner M; Greiner A; Avramidou A; Jäck HM; Niedobitek G
    Hematol Oncol; 2005; 23(3-4):127-32. PubMed ID: 16342298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surfactant protein A detection in primary pulmonary adenocarcinoma without bronchioloalveolar pattern.
    Uzaslan E; Stuempel T; Ebsen M; Freudenberg N; Nakamura S; Costabel U; Guzman J
    Respiration; 2005; 72(3):249-53. PubMed ID: 15942293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bronchioloalveolar carcinoma: the case for two diseases.
    Garfield DH; Cadranel J; West HL
    Clin Lung Cancer; 2008 Jan; 9(1):24-9. PubMed ID: 18282354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mucinous bronchioloalveolar carcinoma of lung with a rhabdoid component--report of a case and review of the literature.
    Song DE; Jang SJ; Black J; Ro JY
    Histopathology; 2007 Sep; 51(3):427-30. PubMed ID: 17727492
    [No Abstract]   [Full Text] [Related]  

  • 30. Mixed mucinous-type and non-mucinous-type adenocarcinoma of the lung: immunohistochemical examination and K- ras gene mutation.
    Maeshima A; Sakamoto M; Hirohashi S
    Virchows Arch; 2002 Jun; 440(6):598-603. PubMed ID: 12070599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. let-7 microRNA expression and the distinction between nonmucinous and mucinous bronchioloalveolar carcinomas.
    Garfield D
    Lung Cancer; 2008 May; 60(2):307. PubMed ID: 18395292
    [No Abstract]   [Full Text] [Related]  

  • 32. [Bronchioloalveolar carcinoma (BAC)].
    Yoshimura A
    Gan To Kagaku Ryoho; 2004 Mar; 31(3):318-21. PubMed ID: 15045932
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of cigarette smoking on prognosis in small adenocarcinomas of the lung: the association between histologic subtype and smoking status.
    Sakao Y; Miyamoto H; Oh S; Takahashi N; Inagaki T; Miyasaka Y; Akaboshi T; Sakuraba M
    J Thorac Oncol; 2008 Sep; 3(9):958-62. PubMed ID: 18758296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
    Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
    J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
    Myong NH
    J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intra-Alveolar Intestinal Epithelium: A Reappraisal of the So-Called Mucinous Goblet-Cell Rich Carcinoma Apropos of Two Cases With Prolonged Follow-up and Literature Review.
    Jessurun J
    Int J Surg Pathol; 2015 May; 23(3):196-201. PubMed ID: 25627070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of p16INK4A expression in lung adenocarcinoma.
    Volm M; Koomägi R; Mattern J
    Anticancer Res; 1998; 18(4A):2309-12. PubMed ID: 9703871
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p16 expression in primary ovarian mucinous and endometrioid tumors and metastatic adenocarcinomas in the ovary: utility for identification of metastatic HPV-related endocervical adenocarcinomas.
    Vang R; Gown AM; Farinola M; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Judson K; Ronnett BM
    Am J Surg Pathol; 2007 May; 31(5):653-63. PubMed ID: 17460447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC
    Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FHIT and p53 gene abnormalities in bronchioloalveolar carcinomas. Correlations with clinicopathological data and K-ras mutations.
    Marchetti A; Pellegrini S; Bertacca G; Buttitta F; Gaeta P; Carnicelli V; Nardini V; Griseri P; Chella A; Angeletti CA; Bevilacqua G
    J Pathol; 1998 Mar; 184(3):240-6. PubMed ID: 9614374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.